Viral vectors for the treatment of alcoholism: Use of metabolic flux analysis for cell cultivation and vector production

Martínez V; Gerdtzen ZP; Andrews, BA; Asenjo, JA

Abstract

The HEK293 cell line has been used for the production of adenovirus vectors to be used in the potential treatment of alcoholism using a gene therapy strategy. Culture optimization and scale-up has been achieved by first adapting the cells to serum-free media and secondly by growing them in suspension. Adenovirus production after infection was increased, resulting in higher specific glucose consumption and lactate accumulation rates compared to the growth phase. We applied media design tools and Metabolic Flux Analysis (MFA) to compare the metabolic states of cells during growth and adenovirus production and to optimize culture media according to the metabolic demand of the cells in terms of glucose and glutamine concentrations. This allowed obtaining a higher maximum cell concentration and increased adenovirus production by minimizing the production of metabolites that can have an inhibitory effect on cell growth. We have proposed a stoichiometric equation for adenovirus synthesis. MFA results allowed determination of how these changes in composition affected the way cells distribute their nutrient resources during cell growth and virus production. Virus purification was successfully achieved using chromatography and Aqueous Two-Phase Systems (ATPS). © 2009 Elsevier Inc. All rights reserved.

Más información

Título según WOS: Viral vectors for the treatment of alcoholism: Use of metabolic flux analysis for cell cultivation and vector production
Título según SCOPUS: Viral vectors for the treatment of alcoholism: Use of metabolic flux analysis for cell cultivation and vector production
Título de la Revista: METABOLIC ENGINEERING
Volumen: 12
Número: 2
Editorial: ACADEMIC PRESS INC ELSEVIER SCIENCE
Fecha de publicación: 2010
Página de inicio: 129
Página final: 137
Idioma: English
URL: http://linkinghub.elsevier.com/retrieve/pii/S109671760900086X
DOI:

10.1016/j.ymben.2009.09.003

Notas: ISI, SCOPUS